Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoyan Chu

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Current Drug Metabolism|February 24, 2021
Absorption, Metabolism, Distribution, and Excretion of LetermovirKarsten Menzel, Prajakti Kothare, Jacqueline B McCrea, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 2016
The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?Xiaoyan Chu, Kelly Bleasby, Grace Hoyee Chan, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|March 27, 2010
[The change of negative pressure in the cupping-cup and its influence on the depth of filiform-needle insertion]Jing Lu, Xiaoyan Chu, Lei Wang, et al.
Clinical Pharmacology and Therapeutics|June 2, 2022
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney DiseaseHiroyuki Takita, Daniel Scotcher, Xiaoyan Chu, et al.
The AAPS Journal|March 22, 2022
In Vitro Assessment of Transporter Mediated Perpetrator DDIs for Several Hepatitis C Virus Direct-Acting Antiviral Drugs and Prediction of DDIs with Statins Using Static ModelsXiaoyan Chu, Grace Hoyee Chan, Robert Houle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor MethodGrace Hoyee Chan, Robert Houle, Jinghui Zhang, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2019
Role of transporters in the disposition of a novel β-lactamase inhibitor: relebactam (MK-7655)Grace Chan, Robert Houle, Meihong Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2013
Understanding the transport properties of metabolites: case studies and considerations for drug developmentMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Joseph W Polli, et al.
Nucleic Acids Research|January 9, 2009
Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytesNiresh Hariparsad, Xiaoyan Chu, Jocelyn Yabut, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2013
Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluationMatthew L Rizk, Robert Houle, Grace Hoyee Chan, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Current Drug Metabolism|February 24, 2021
Absorption, Metabolism, Distribution, and Excretion of LetermovirKarsten Menzel, Prajakti Kothare, Jacqueline B McCrea, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 2016
The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?Xiaoyan Chu, Kelly Bleasby, Grace Hoyee Chan, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|March 27, 2010
[The change of negative pressure in the cupping-cup and its influence on the depth of filiform-needle insertion]Jing Lu, Xiaoyan Chu, Lei Wang, et al.
Clinical Pharmacology and Therapeutics|June 2, 2022
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney DiseaseHiroyuki Takita, Daniel Scotcher, Xiaoyan Chu, et al.
The AAPS Journal|March 22, 2022
In Vitro Assessment of Transporter Mediated Perpetrator DDIs for Several Hepatitis C Virus Direct-Acting Antiviral Drugs and Prediction of DDIs with Statins Using Static ModelsXiaoyan Chu, Grace Hoyee Chan, Robert Houle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
Evaluation of the Selectivity of Several Organic Anion Transporting Polypeptide 1B Biomarkers Using Relative Activity Factor MethodGrace Hoyee Chan, Robert Houle, Jinghui Zhang, et al.
The Journal of Antimicrobial Chemotherapy|March 21, 2019
Role of transporters in the disposition of a novel β-lactamase inhibitor: relebactam (MK-7655)Grace Chan, Robert Houle, Meihong Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2013
Understanding the transport properties of metabolites: case studies and considerations for drug developmentMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Joseph W Polli, et al.
Nucleic Acids Research|January 9, 2009
Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytesNiresh Hariparsad, Xiaoyan Chu, Jocelyn Yabut, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2013
Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluationMatthew L Rizk, Robert Houle, Grace Hoyee Chan, et al.
Pageof 8